HQIP / Resources / National Cardiac Audit Programme 2022 Report: The heart in lockdown
National Cardiac Audit Programme 2022 Report: The heart in lockdown
Reports, Patient Focused Reports |
Published: 16 Jun 2022
The National Cardiac Audit Programme (NCAP) has published its 2022 annual report. Based on data from 1 April 2020 to 31 March 2021, the report focuses on how cardiovascular services were impacted by the first year of the COVID-19 pandemic. NCAP comprises of six domains, each of which is concerned with a particular cardiovascular disease area or treatment (for which individual reports can also be found using these links):
The National Congenital Heart Disease Audit (NCHDA)
The Myocardial Ischaemia National Audit Project (MINAP)
The National Audit of Percutaneous Coronary Interventions (NAPCI)
The National Adult Cardiac Surgery Audit (NACSA)
The National Heart Failure Audit (NHFA)
The National Audit of Cardiac Rhythm Management (NACRM)
This annual report found that overall acute admissions were down during 2020/21, with a 9% reduction in those with STEMI, 18% fall in those with NSTEMI and a 12% fall in admissions for heart failure. Other key findings include:
Antenatal detection of congenital heart defects requiring intervention in the first year improved to 52%
More STEMI patients were investigated by echocardiography – now 77%
There was increased referral of heart attack patients to cardiac rehabilitation – exceeded the 85% target at the end of 2020/21
The mortality for most cardiac interventions remained unchanged (for example, all PCI 2%, PPCI 5.5%, and NSTEMI PCI 0.75%).
The report also found that there were substantial drops in acute cardiovascular admissions during the first wave of COVID-19 hospitalisations and, while the reductions in the second COVID-19 wave were significant, they were smaller for all procedures except for PPCI.
Read the full report: You can read the report by clicking on the link below.
Stay-up-to-date: For notifications of future reports from HQIP, sign up to our mailing list.